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How does lung function in early adulthood influence subsequent health outcomes? 
Agusti and colleagues address this question in their recent observational study1, to 
show that low lung function in early adulthood is associated with earlier onset of 
COPD, other chronic diseases as well as death.  
 
Chronic obstructive pulmonary disease (COPD) is an important contributor to the 
burden of non-communicable diseases, making up 2.6% of the global burden of 
disease in 2015.2 An increased rate of decline in lung function from early adulthood 
onwards is associated with COPD.3 Furthermore, recent studies have shown increased 
incidence of COPD in people with normal levels of lung function decline, but who 
have reached a sub-optimal lung function “plateau” in early adult life.4 This suggests 
a fundamentally new concept in COPD, where the factors that determine the 
achievement of the optimum stock of lung health in early adulthood are centre stage, 
as these are recognised as major drivers in the pathogenesis of the disease.5  
 
In this context, the motivation for the Agusti et al., study is to better understand how 
lung function impact the risk of later adult chronic disease. To do this the authors 
analyse data from two large independent US cohorts (the Framingham Offspring 
Cohort (FOC) and the Coronary Artery Risk Development in Young Adults Study 
(CARDIA), and also the Framingham Generation III cohort (GenIII). The latter 
cohort includes the offspring of FOC, which allows exploration of potential 
intergenerational associations of low lung function.   
 
The authors assess cross-sectional associations between low lung function in early 
adulthood (dichotomizing FEV1 into low and high based on FEV1 < 80% predicted 
between the ages of 25 and 40 years) and indicators of disease risk.  The low lung 
function group (between 4-12% of the cohort population) had worse physiological, 
clinical and laboratory outcomes. For instance, the low lung function group were 
more likely to be smokers; overweight, diagnosed with respiratory diseases; have 
higher prevalence of diabetes and hypertension; and higher circulating leukocyte 
counts. The cross-sectional nature of these multiple associations makes inference 
about causation challenging. There is also the potential problem of detection bias, 
whereby those with low lung function were more likely to be seen clinically and 
tested for some of the outcomes. However, the emerging picture from the analysis is 
unsurprisingly one of a range of related, and biologically plausible adverse 
physiological and clinical indicators associated with low lung function in early 
adulthood.  
 
The longitudinal findings from these cohort studies are far more informative. Low 
lung function in early adulthood is the baseline exposure, and participants are 
followed up into later life to assess time to first reported comorbidity (respiratory, 
cardiovascular, metabolic and/or cancer) or death. The low lung function group have 
earlier onset of adult chronic diseases, and death in the FOC and CARDIA cohorts.  
Smoking and low lung function were independently associated with time to first onset 
of multi-morbidity, and had additive effects. In the final part of the analysis, the 
authors compare two groups in GENIII stratified on the basis of parental lung 
function level (high v low) and show that parental FEV1 is concordant with that of the 
offspring. This suggests some “trans-generational reproducibility” of low lung 
function, but does not provide evidence about the relative importance of genetic, 
environmental or socioeconomic influences. 
 
The study by Agusti and colleagues is important in that it examines a life course 
approach to the development of COPD, and corroborates the findings of Lange and 
colleagues, who made use of US and Danish cohorts to demonstrate the association 
between low lung function in early adulthood and subsequent COPD risk4. Augusti 
and colleagues extend these findings to show that low lung function is associated with 
multi-morbidity and death in later adulthood. A limitation of the study is that it cannot 
unravel the complex relationship between genetic and environmental early life 
exposures, low lung function and subsequent adverse outcomes in later adulthood. 
More research is needed in longitudinal studies, using modern statistical mediation 
approaches6, to better establish these causal pathways, in order to identify targets and 
times for clinical and public health intervention. Linking these findings to those of 
paediatric cohorts with lung function measurements will also be important to 
understand the critical windows for lung function development and how early these 
associations are established.   
 
The authors speculate that spirometry may be a useful screening tool in early adult 
life, in order to predict later adverse health outcomes, but this is not supported by the 
data in the present analysis. It is unclear how well FEV1 % predicted predicts poor 
outcomes, with no assessment of the sensitivity or specificity (or false positive or 
false negative rates) for the use of low lung function as a predictor of subsequent poor 
health or outcomes, and the significant with person error inherent in FEV1 
measurement presents further challenges.7 Furthermore, the analysis dichotomizes 
FEV1 using a fixed cut-off, rather than an age appropriate lower limit of normal, 
which artificially separates the groups. It is more likely that FEV1 is associated with 
outcomes on a spectrum, and that screening algorithms can be designed to be more 
precise.   
 
From a public health perspective, Agusti and colleagues study supports the growing 
consensus that early risks to health track forward, to influence multiple domains of 
adult health in later life.8,9 This has important implications for public health policy, 
and suggests the need for a shift to an early optimisation paradigm of lung health, 
whereby policies and practices support children and young adults to adopt optimum 
lung health trajectories. This will involve an increased public health focus on the 
determinants of lung health across the life course, optimising early growth and 
nutrition, reducing early infections, and addressing the major risk factors of tobacco 
smoking and air pollution. 
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